drugset
drugset / Trial / NCT03927170

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed)

NCT03927170 ↗

Phase 1 Completed 25 enrolled GL Pharm Tech Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

Crossover study to compare the pharmacokinetic characteristics of GLH1SM sustained release tablet and Janumet XR tablet in fed condition

Timeline

Start
2019-05-02
Primary completion
2019-09-11
Completion
2019-10-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg —
Subject Sitagliptin Small molecule 100 mg —

Indications

No indication recorded.